201 related articles for article (PubMed ID: 22300139)
21. Physiologic functions of PP2A: Lessons from genetically modified mice.
Reynhout S; Janssens V
Biochim Biophys Acta Mol Cell Res; 2019 Jan; 1866(1):31-50. PubMed ID: 30030003
[TBL] [Abstract][Full Text] [Related]
22. Protein Phosphatase 2A: a Double-Faced Phosphatase of Cellular System and Its Role in Neurodegenerative Disorders.
Nematullah M; Hoda MN; Khan F
Mol Neurobiol; 2018 Feb; 55(2):1750-1761. PubMed ID: 28224476
[TBL] [Abstract][Full Text] [Related]
23. Specialized functions of the PP2A subfamily II catalytic subunits PP2A-C3 and PP2A-C4 in the distribution of auxin fluxes and development in Arabidopsis.
Ballesteros I; Domínguez T; Sauer M; Paredes P; Duprat A; Rojo E; Sanmartín M; Sánchez-Serrano JJ
Plant J; 2013 Mar; 73(5):862-72. PubMed ID: 23167545
[TBL] [Abstract][Full Text] [Related]
24. Cancer-specific toxicity of apoptin is independent of death receptors but involves the loss of mitochondrial membrane potential and the release of mitochondrial cell-death mediators by a Nur77-dependent pathway.
Maddika S; Booy EP; Johar D; Gibson SB; Ghavami S; Los M
J Cell Sci; 2005 Oct; 118(Pt 19):4485-93. PubMed ID: 16179607
[TBL] [Abstract][Full Text] [Related]
25. Ser70 phosphorylation of Bcl-2 by selective tyrosine nitration of PP2A-B56δ stabilizes its antiapoptotic activity.
Low IC; Loh T; Huang Y; Virshup DM; Pervaiz S
Blood; 2014 Oct; 124(14):2223-34. PubMed ID: 25082878
[TBL] [Abstract][Full Text] [Related]
26. Silencing of the PP2A catalytic subunit causes HER-2/neu positive breast cancer cells to undergo apoptosis.
Wong LL; Zhang D; Chang CF; Koay ES
Exp Cell Res; 2010 Dec; 316(20):3387-96. PubMed ID: 20558158
[TBL] [Abstract][Full Text] [Related]
27. Structure, regulation, and pharmacological modulation of PP2A phosphatases.
Lambrecht C; Haesen D; Sents W; Ivanova E; Janssens V
Methods Mol Biol; 2013; 1053():283-305. PubMed ID: 23860660
[TBL] [Abstract][Full Text] [Related]
28. Protein phosphatase 2A: a target for anticancer therapy.
Perrotti D; Neviani P
Lancet Oncol; 2013 May; 14(6):e229-38. PubMed ID: 23639323
[TBL] [Abstract][Full Text] [Related]
29. A signalling pathway controlling c-Myc degradation that impacts oncogenic transformation of human cells.
Yeh E; Cunningham M; Arnold H; Chasse D; Monteith T; Ivaldi G; Hahn WC; Stukenberg PT; Shenolikar S; Uchida T; Counter CM; Nevins JR; Means AR; Sears R
Nat Cell Biol; 2004 Apr; 6(4):308-18. PubMed ID: 15048125
[TBL] [Abstract][Full Text] [Related]
30. Carnosic acid modulates Akt/IKK/NF-κB signaling by PP2A and induces intrinsic and extrinsic pathway mediated apoptosis in human prostate carcinoma PC-3 cells.
Kar S; Palit S; Ball WB; Das PK
Apoptosis; 2012 Jul; 17(7):735-47. PubMed ID: 22453599
[TBL] [Abstract][Full Text] [Related]
31. Zoledronic acid in combination with serine/threonine phosphatase inhibitors induces enhanced cytotoxicity and apoptosis in hormone-refractory prostate cancer cell lines by decreasing the activities of PP1 and PP2A.
Cirak Y; Varol U; Atmaca H; Kisim A; Sezgin C; Karabulut B; Uzunoglu S; Uslu R; Karaca B
BJU Int; 2012 Dec; 110(11 Pt C):E1147-54. PubMed ID: 22882676
[TBL] [Abstract][Full Text] [Related]
32. Therapeutic targeting of PP2A.
O'Connor CM; Perl A; Leonard D; Sangodkar J; Narla G
Int J Biochem Cell Biol; 2018 Mar; 96():182-193. PubMed ID: 29107183
[TBL] [Abstract][Full Text] [Related]
33. Apoptosis signalling pathways in seizure-induced neuronal death and epilepsy.
Henshall DC
Biochem Soc Trans; 2007 Apr; 35(Pt 2):421-3. PubMed ID: 17371290
[TBL] [Abstract][Full Text] [Related]
34. The role of apoptosis repressor with a CARD domain (ARC) in the therapeutic resistance of renal cell carcinoma (RCC): the crucial role of ARC in the inhibition of extrinsic and intrinsic apoptotic signalling.
Toth C; Funke S; Nitsche V; Liverts A; Zlachevska V; Gasis M; Wiek C; Hanenberg H; Mahotka C; Schirmacher P; Heikaus S
Cell Commun Signal; 2017 May; 15(1):16. PubMed ID: 28464919
[TBL] [Abstract][Full Text] [Related]
35. Protein phosphatase 2A-linked and -unlinked caspase-dependent pathways for downregulation of Akt kinase triggered by 4-hydroxynonenal.
Liu W; Akhand AA; Takeda K; Kawamoto Y; Itoigawa M; Kato M; Suzuki H; Ishikawa N; Nakashima I
Cell Death Differ; 2003 Jul; 10(7):772-81. PubMed ID: 12815460
[TBL] [Abstract][Full Text] [Related]
36. Tyrosine phosphorylation of PP2A is regulated by HER-2 signalling and correlates with breast cancer progression.
Wong LL; Chang CF; Koay ES; Zhang D
Int J Oncol; 2009 May; 34(5):1291-301. PubMed ID: 19360341
[TBL] [Abstract][Full Text] [Related]
37. Protein phosphatase 2A as a new target for morphogenetic studies in the chick limb.
Viallet J; Garcia A; Weydert A
Biochimie; 2003 Aug; 85(8):753-62. PubMed ID: 14585542
[TBL] [Abstract][Full Text] [Related]
38. Protein phosphatase 2A as therapeutic targets in various disease models.
Baskaran R; Velmurugan BK
Life Sci; 2018 Oct; 210():40-46. PubMed ID: 30170071
[TBL] [Abstract][Full Text] [Related]
39. Protein phosphatase 2A: a highly regulated family of serine/threonine phosphatases implicated in cell growth and signalling.
Janssens V; Goris J
Biochem J; 2001 Feb; 353(Pt 3):417-39. PubMed ID: 11171037
[TBL] [Abstract][Full Text] [Related]
40. Protein phosphatase 2A regulates bim expression via the Akt/FKHRL1 signaling pathway in amyloid-beta peptide-induced cerebrovascular endothelial cell death.
Yin KJ; Hsu CY; Hu XY; Chen H; Chen SW; Xu J; Lee JM
J Neurosci; 2006 Feb; 26(8):2290-9. PubMed ID: 16495456
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
